Posted in | News | Nanomaterials and Nanotechnology | Fibers

New Manganese Oxide Catalyst Capable of Destroying Volatile Organic Compounds

Dec 20 2006

Related Stories

American Elements’ Nanometal™ division announced today the development of a new manganese oxide nanofiber catalyst capable of destroying volatile organic compounds (V.O.C.s) in air emissions to part per billion (ppb) ranges. This proprietary nano scale form of manganese oxide will be marketed under the trademark “Mangasorb™”.

Mangasorb™ can destroy nearly 50 RICRA regulated Hazardous Waste VOCs when coated on high surface area substrates. Mangasorb™ is a next generation technology for catalytic removal of VOCs from industrial waste air emissions. The product is available in lot sizes up to 1,000 kg. Small orders are also available for university and corporate R&D programs. American Elements’ Mangasorb™ product line includes nanopowder that range in size from 10 nm to 1 micron.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback